Health Care · Life Sciences Tools & Services
Thermo Fisher Scientific Inc TMO
$532.48-10.71 (-1.97%)delayed quote · as of 2026-07-17 20:58 UTC
Market cap
$197.9B
Previous close
$543.19
Volume
1.1M
52-week range
$403.36 – $643.99
Verdictconfidence 100% · high
A mixed picture across the dimensions we score.
4 of 5 dimensions score well; growth flashes caution.
Value603/5 checks
Growth402/5 checks
Quality603/5 checks
Health603/5 checks
Momentum603/5 checks
Fair-value estimate $595.83 per share (2-stage FCF · individual beta · 10Y Rf 4.6%) — the price sits 11% below it.
Every check behind these scores — with its numbers, source, and evidence link — is in the workspace.
Key ratioslatest filing FY 2025
Value
P/E TTM
29.4
P/E NTM
19.9
EV/EBITDA
21.4
PEG
1.76
FCF yield
3.2%
Growth
Revenue 3y
−0.3%/yr
Revenue YoY
+3.9%
Expected EPS
+47.6%
Quality
Piotroski F
6 / 9
ROIC
ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-17 20:58 UTC · fundamentals FY 2025 · SEC EDGAR
Continue with TMO in ALAN
Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.
For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.